Enhancement of chemosensitivity toward anticancer drugs by high expression of caspase-1 in NIH 3T3 cells

Anti-Cancer Drugs

Volumn 9, Issue 1, 1998, Pages 82-87

  Hiwasa, Takaki ^a   Tokita, Hisashi ^b   Sakiyama, Shigeru ^b   Nakagaware, Akira ^b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA CANCER CENTER   (Japan)

Author keywords

Anticancer drug; Apoptosis; Caspase

Indexed keywords

ACLARUBICIN; ANTINEOPLASTIC AGENT; CASPASE 2; CASPASE 3; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; INTERLEUKIN 1BETA CONVERTING ENZYME; NIMUSTINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHEMOSENSITIVITY; CYTOTOXICITY; FIBROBLAST; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 1; CYSTEINE ENDOPEPTIDASES; DEXAMETHASONE; MICE; TRANSFECTION;

EID: 0031887784     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199801000-00010     Document Type: Article

References (32)

1. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1-β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993; 75: 653-60.
2. Wang L, Miura M, Bergeron L, Zhu H, Yuan J. Ich-1, and Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78: 739-50.
3. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhadbitis elegans cell death gene ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev 1994; 8: 1613-26.
4. relIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem 1995; 270: 15870-6.
5. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801-9.
6. Enari M, Hug H, Nagata S, Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375: 78-81.
7. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
8. Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-72.
9. Brancolini C, Benedetti M, Schneider C. Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J 1995; 14: 5179-90.
10. Emoto Y, Manome Y, Meinhardt G, et al. Proteolytic activation of protein kinase Cδ by an ICE-like protease in apoptotic cells. EMBO J 1995; 14: 6148-56.
11. Mashima T, Naito M, Fujita N, Noguchi K, Tsuruo T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun 1995; 217: 1185-92.
12. An B, Dou QP. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1β-converting enzyme-like protease as candidate. Cancer Res 1996; 56: 438-42.
13. Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 1996; 135: 1441-55.
14. Vanags DM, Pörn-Ares MI, Coppola S, Burgess DH, Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 1996; 271: 31075-85.
15. Teraoka H, Yumoto Y, Watanabe F, et al. CPP32/Yama/apopain cleaves the catalytic component of DNA-High chemosensitivity of ICE-transfected cells dependent protein kinase in the holoenzyme. FEBS Lett 1996; 393: 1-6.
16. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
17. Hickman JA. Apoptosis and chemotherapy resistance. Eur J Cancer 1996; 32A: 921-6.
18. Senokuchi K, Nakai H, Nakayama Y, et al. New orally active serine protease inhibitors. J Med Chem 1995; 38: 2521-3.
19. Hiwasa T, Sawada T, Sakiyama S. Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward NIH 3T3 mouse fibroblasts and the differentiation-inducing activity toward PC12 rat pheochromocytoma cells. Carinogenesis 1990; 11: 75-80.
20. Hiwasa T, Ma J, Ike Y, Katunuma N, Sakiyama S. Increase of cyclin B by overexpression of cystatin α. Cell Biochem Funct 1995; 13: 293-6.
21. Hiwasa T, Kominami E. Physical association of Ras and cathepsins B and L in the conditioned medium of v-Ha-RAS-transformed NIH 3T3 cells. Biochem Biophys Res Commun 1995; 216: 828-34.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
23. Hiwasa T, Soeda C, Takanohashi S, et al. Screening of peptides which suppress the proliferation of transformed cells. Int J Oncol 1996; 8: 125-9.
24. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
25. Seamus MJ, Seamus LV, Aines BM, Thomas CG. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of protein or RNA synthesis. J Immunol 1990; 145: 1859-67.
26. Bertrand R, Solary E, O'Connor P, Kohm KW, Pommier Y. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 1994; 211: 314-21.
27. Hiwasa T. Induction of apoptosis by a calpain stimulator. ONO-3403. Apoptosis 1996; 1: 75-80.
28. Zhu W., Murtha PE, Young CYF. Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells. Biochem Biophys Res Commun 1995; 214: 1130-7.
29. Hiwasa T, Tokita H, Ike Y. Differential chemosensitivity in oncogene-transformed cells. J Exper Ther Oncol 1996; 1: 162-70.
30. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 5556.
31. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenprhabditis elegans cell death protein Ced-3 and mammalian interleukin-1-β-converting enzyme. J Biol Chem 1994; 269: 30761-4.
32. Miossec C, Dutilleul V, Fassy F, Diu-Hercend A. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J Biol Chem 1997; 272: 13459-62.